Znn3bq.jpeg
ÉÇÍ·´óѧº£Ñó¿ÆÑ§½ÓÊܵ÷¼Á
²é¿´: 804  |  »Ø¸´: 7
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

caohouping

ľ³æ (ÕýʽдÊÖ)

[ÇóÖú] ÇâÂÈàçàºEP7.6ÖÊÁ¿±ê×¼

ÇâÂÈàçàºEP7.6ÖÊÁ¿±ê×¼£¬ÇóÖú£¡Ð»Ð»¸÷λÁË
»Ø¸´´ËÂ¥
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

³ÕÒÄ×ÓÆ¤

°æÖ÷ (ÎÄ̳¾«Ó¢)

ÀÏÆ¦

ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
yuanahen: ½ð±Ò+2, ¸Ðл²ÎÓ룬ÆÚ´ý¸ü¶àÓмÛÖµµÄÌû×Ó 2013-07-09 08:51:50
caohouping: ½ð±Ò+5, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, ллÀÏ´ó 2013-07-09 09:48:20
ÊØºòÔÚ·çÖеÄÄþ¾²¡£
7Â¥2013-07-09 08:44:15
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 8 ¸ö»Ø´ð

so0325

ľ³æ (СÓÐÃûÆø)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
ºÓ±ßµÄ«έ: ½ð±Ò+1, ¸ÐлÄãµÄ»ØÌû½»Á÷~ 2013-07-08 15:22:52
ºÓ±ßµÄ«έ: »ØÌûÖö¥ 2013-07-08 15:22:57
BP2013µÄ¿ÉÒÔ²»£¬»ù±¾ÊÇÕÕ×ÅEP°ÇÏÂÀ´µÄ

» ±¾Ìû¸½¼þ×ÊÔ´Áбí

  • »¶Ó­¼à¶½ºÍ·´À¡£ºÐ¡Ä¾³æ½öÌṩ½»Á÷ƽ̨£¬²»¶Ô¸ÃÄÚÈݸºÔð¡£
    ±¾ÄÚÈÝÓÉÓû§×ÔÖ÷·¢²¼£¬Èç¹ûÆäÄÚÈÝÉæ¼°µ½ÖªÊ¶²úȨÎÊÌ⣬ÆäÔðÈÎÔÚÓÚÓû§±¾ÈË£¬Èç¶Ô°æÈ¨ÓÐÒìÒ飬ÇëÁªÏµÓÊÏ䣺xiaomuchong@tal.com
  • ¸½¼þ 1 : ÇâÂÈàçàº-BP2013.rar
  • 2013-07-08 14:20:38, 120.74 K
2Â¥2013-07-08 14:20:51
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

caohouping

ľ³æ (ÕýʽдÊÖ)

ÒýÓûØÌû:
2Â¥: Originally posted by so0325 at 2013-07-08 14:20:51
BP2013µÄ¿ÉÒÔ²»£¬»ù±¾ÊÇÕÕ×ÅEP°ÇÏÂÀ´µÄ

²»Ò»ÑùµÄ
4Â¥2013-07-08 17:55:52
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

caohouping

ľ³æ (ÕýʽдÊÖ)

SUPPLEMENT 7.6
Related substances: in line with the general monograph Substances for pharmaceutical use (2034), an explicit acceptance criterion for unspecified impurities has been introduced; in addition, relative retentions of specified impurities are now given, and a peak identification CRS has been introduced to allow the identification of specified impurities.

SUPPLEMENT 7.4
Content: lower limit updated to reflect change in assay method.
Assay: titration replaced by LC.

SUPPLEMENT 6.4
Characters: the substance shows polymorphism.
PUBLICATION 6.0
Identification: IR spectra might show differences that disappear after recrystallisation: corresponding statement added.
5Â¥2013-07-08 17:57:03
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ²ÄÁÏÀà284µ÷¼Á +42 Ïë»»ÊÖ»ú²»Ïë½âÊ 2026-04-08 50/2500 2026-04-15 06:09 by åÐÒ£ÈýÀÉ
[¿¼ÑÐ] 272·Ö²ÄÁÏ×ÓÇóµ÷¼Á +41 Loy0361 2026-04-10 54/2700 2026-04-14 18:00 by lhj2009
[¿¼ÑÐ] ҩѧ305Çóµ÷¼Á +10 Â꿨°Í¿¨boom 2026-04-10 10/500 2026-04-14 15:55 by zs92450
[¿¼ÑÐ] ÉúÎïѧµ÷¼Á +7 Ö½ÉÈzhishan 2026-04-13 7/350 2026-04-14 14:21 by jyl0317
[¿¼ÑÐ] Çóµ÷¼Á288 +7 ioodiiij 2026-04-10 9/450 2026-04-13 08:33 by Hayaay
[¿¼ÑÐ] 322Çóµ÷¼Á£¬08¹¤¿Æ +4 ½ñÌìÊǸöСºÅ 2026-04-08 4/200 2026-04-13 00:20 by baobaoye
[¿¼ÑÐ] 296Çóµ÷¼Á +14 Íô£¡£¿£¡ 2026-04-10 16/800 2026-04-12 10:48 by zhouyuwinner
[¿¼ÑÐ] Çóµ÷¼Á +6 archer.. 2026-04-09 8/400 2026-04-11 10:55 by zhq0425
[¿¼ÑÐ] 311Çóµ÷¼Á +13 xypÏë¶ÁÊé 2026-04-10 14/700 2026-04-11 09:41 by Öí»á·É
[¿¼ÑÐ] 22408µ÷¼ÁÇóÖú +7 ì±12 2026-04-09 9/450 2026-04-11 09:23 by ŶŶ123
[¿¼ÑÐ] Ò»Ö¾Ô¸±±Àí¹¤298Ó¢Ò»Êý¶þÒÑÉϰ¶£¬¸Ðл¸÷λÀÏʦ +14 Reframe 2026-04-10 16/800 2026-04-10 23:07 by caotw2020
[¿¼ÑÐ] µ÷¼Á +12 ¾í¾í¾íÐIJË_ 2026-04-09 13/650 2026-04-10 22:36 by Ftglcn90
[¿¼ÑÐ] »úеר368 ÓÐÈ¥´¦Âð +4 ÖÖ´óÊ÷ 2026-04-10 4/200 2026-04-10 15:31 by jiajinhpu
[¿¼ÑÐ] Çóµ÷¼Á ²ÄÁÏÓ빤³Ì 324·Ö ר˶ +19 ôæôæÒ»ÊéÉú 2026-04-10 21/1050 2026-04-10 11:41 by wp06
[¿¼ÑÐ] 296Çóµ÷¼Á +6 Íô£¡£¿£¡ 2026-04-08 6/300 2026-04-10 11:02 by mattzhming
[¿¼ÑÐ] Ò»Ö¾Ô¸ÖÐÄÏ´óѧÎïÀíѧ£¬Ó¢Ò»66£¬Çóµ÷¼Á +4 ³¤ÑÌì½ì» 2026-04-08 5/250 2026-04-10 10:31 by Ó±¹û¶ù
[¿¼ÑÐ] ±¾¿ÆÎ÷¹¤´ó 0856 324Çóµ÷¼Á +10 wysyjs25 2026-04-09 11/550 2026-04-10 08:37 by 5268321
[¿¼ÑÐ] 337Çóµ÷¼Á +4 Gky09300550£¬ 2026-04-09 4/200 2026-04-09 17:18 by ÅÁ¶ûÂíÀ­ÌØ
[¿¼ÑÐ] ¸´ÊÔµ÷¼Á£¬Ò»Ö¾Ô¸Ö£ÖÝ´óѧ²ÄÁÏÓ뻯¹¤289·Ö +31 ˶ÐǸ° 2026-04-08 31/1550 2026-04-09 16:54 by Delta2012
[¿¼ÑÐ] ¶þ´Îµ÷¼ÁÇóÀÏʦÊÕÁô +3 ЦЦԬ 2026-04-08 3/150 2026-04-08 23:50 by ×íÔÚ·çÀï
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û